High Flow Nasal Cannula With Noninvasive Ventilation

Acute Respiratory Failure Clinical Trial

Official title:

High Flow Nasal Cannula With Noninvasive Ventilation and Its Effect on High Risk Trauma Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04507425
• Other study ID #: 12248
• Status: Completed
• Phase: N/A
• Start date: September 1, 2020
• Est. completion date: July 10, 2023

Study information

• Verified date: November 2023
• Source: University of Oklahoma
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a prospective, randomized, unblinded trial of trauma patients in the ICU who are identified as being at a high risk to develop acute respiratory failure. We hope that this study will help the study team to identify how best to use a more aggressive respiratory treatment strategy in a high risk trauma population (thoracic trauma or trauma patients requiring thoracic surgery, spine surgery, or open abdominal procedures) to try and decrease the need for intubation with mechanical ventilation.

Description:

All patients consented will be randomly assigned into one of three groups: nasal cannula (control group, our current standard of care), high-flow nasal cannula, high-flow nasal cannula plus noninvasive ventilation. After obtaining consent, patient will be randomized to interventions 1:1:1 within each of two groups: patients admitted to the ICU without being intubated OR intubated patients undergoing an extubation. Randomization will be managed through RedCap. After consent, the treating clinician will log into RedCap to obtain the patient's treating assignment. The primary outcome of interest is failure of conservative ventilation intervention in prevention of initial intubation or prevention of reintubation. A chart review of all enrolled patients will be done quarterly to assess morbidity, mortality, and outcomes. No placebo will be used as all qualifying patients will be placed on nasal cannula, high-flow nasal cannula, or high-flow nasal cannula plus noninvasive ventilation. All other treatments will be standard of care. Participants in the study will continue until the patient is discharged from the trauma ICU. The study will end when the last person enrolled has been discharged from the trauma ICU. If patient's participation ends prematurely, available data will be entered into the database and evaluated appropriately. This study will take place at the OU Medical Center (OUMC) among patients admitted to the Trauma Intensive Care Unit. Consent for study enrollment will take place at OUMC during discussion with physician providing trauma care and the patient, family member, or next of kin consenting for the study. The following data will be collected and recorded: Supplemental oxygen requirements, Date/Time of arrival, Date/Time of Admission to ICU, Date/Time of intubation procedure, Date/Time of extubation, Ventilator settings, Duration of intubation, Comorbidities, PaCO2 values, PaO2 values, Vital signs at arrival and at admission to ICU, Age,Gender, Weight, Height, BMI, Traumatic injuries, Diagnosis, Past medical history/medical co-morbidities, Glasgow coma scale, Oxygen saturation, Negative inspiratory force score, Rapid shallow breathing index score, Pulmonary treatments, including an intolerance to therapy, Injury Severity Score (ISS) and/or Abbreviated Injury Scale (AIS).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 6
• Est. completion date: July 10, 2023
• Est. primary completion date: July 10, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

1. Adults at least 18 years of age

2. Admission to an intensive care unit by the trauma surgery service

3. Trauma patients receiving any respiratory therapies

4. High risk patients, including intubation, post-operative, chronic cardiac or pulmonary comorbidities

5. Thoracic injuries, including rib fractures, sternal fractures, spinal fractures, pulmonary contusions, pneumothorax, hemothorax, diaphragm injury

6. Postoperative from thoracic surgery

7. Postoperative from spine surgery in patients without spinal cord injury

8. Abdominal injuries requiring open abdominal surgery

9. No contraindications to using high flow nasal cannula or noninvasive ventilation

Exclusion Criteria:

1. Contraindication to using high flow nasal cannula or noninvasive ventilation

2. Intolerance of pulmonary therapies

3. No one able to give informed consent

4. Long-term treatment with noninvasive ventilation prior to hospital admission

5. "Do not intubate" order at time of extubation

6. Unplanned extubation (accidental or self-extubation)

7. Age < 18 years of age

8. Traumatic brain injury with GCS < 8

9. Spinal cord injury

10. Chronic neuromuscular disease

11. Sinus precautions due to facial/sinus fractures

Related Conditions & MeSH terms

• Acute Respiratory Failure
• Respiratory Insufficiency

Intervention

Other:
• Standard of Care - Nasal Cannula
Standard of care. Flexible tube to provide extra oxygen when patients need a little help, but are not in respiratory distress.
• High-flow nasal cannula
Same as nasal cannula, except the oxygen is heated or humidified and the flow is stronger, pushing air into the lungs to help keep the airway open.
• HFNC plus non-invasive ventilation
This method uses HFNC as described above and adds noninvasive ventilation which is similar to CPAP machine and uses a mask rather than having to intubate (putting a tube down your throat to keep your airway from collapsing).

Locations

Country	Name	City	State
United States	OU Medical Center	Oklahoma City	Oklahoma

Sponsors (1)

Lead Sponsor	Collaborator
University of Oklahoma

Country where clinical trial is conducted

United States, 

References & Publications (7)

Gaunt KA, Spilman SK, Halub ME, Jackson JA, Lamb KD, Sahr SM. High-Flow Nasal Cannula in a Mixed Adult ICU. Respir Care. 2015 Oct;60(10):1383-9. doi: 10.4187/respcare.04016. Epub 2015 Jun 9. — View Citation

Halub ME, Spilman SK, Gaunt KA, Lamb KD, Jackson JA, Oetting TW, Sahr SM. High-flow nasal cannula therapy for patients with blunt thoracic injury: A retrospective study. Can J Respir Ther. 2016 Fall;52(4):110-113. Epub 2016 Nov 1. — View Citation

Honrubia T, Garcia Lopez FJ, Franco N, Mas M, Guevara M, Daguerre M, Alia I, Algora A, Galdos P. Noninvasive vs conventional mechanical ventilation in acute respiratory failure: a multicenter, randomized controlled trial. Chest. 2005 Dec;128(6):3916-24. d — View Citation

Lamb KD, Spilman SK, Oetting TW, Jackson JA, Trump MW, Sahr SM. Proactive Use of High-Flow Nasal Cannula With Critically Ill Subjects. Respir Care. 2018 Mar;63(3):259-266. doi: 10.4187/respcare.05793. Epub 2017 Dec 5. — View Citation

Thille AW, Boissier F, Ben-Ghezala H, Razazi K, Mekontso-Dessap A, Brun-Buisson C, Brochard L. Easily identified at-risk patients for extubation failure may benefit from noninvasive ventilation: a prospective before-after study. Crit Care. 2016 Feb 26;20: — View Citation

Thille AW, Muller G, Gacouin A, Coudroy R, Decavele M, Sonneville R, Beloncle F, Girault C, Dangers L, Lautrette A, Cabasson S, Rouze A, Vivier E, Le Meur A, Ricard JD, Razazi K, Barberet G, Lebert C, Ehrmann S, Sabatier C, Bourenne J, Pradel G, Bailly P, — View Citation

Xu Z, Li Y, Zhou J, Li X, Huang Y, Liu X, Burns KEA, Zhong N, Zhang H. High-flow nasal cannula in adults with acute respiratory failure and after extubation: a systematic review and meta-analysis. Respir Res. 2018 Oct 16;19(1):202. doi: 10.1186/s12931-018 — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	failure rates-nonintubated patients	Among injured patients admitted to the intensive care unit (ICU) without being intubated, do failure rates within the first 48 hours of ICU admission differ with respect to type of initial respiratory intervention: nasal cannula, high-flow nasal cannula (HFNC), or HFNC plus non-invasive ventilation (BiPAP). Failure is defined as escalation to intubation.	first 48 hours
Primary	failure rates-intubated patients	Among injured patients arriving intubated or who undergo intervention after hospital arrival, do failure rates within the first 48 hours after extubation differ with respect to type of initial respiratory intervention: nasal cannula, high-flow nasal cannula (HFNC), or HFNC plus non-invasive ventilation (BiPAP). Failure is defined as requiring reintubation.	first 48 hours
Secondary	Mortality	Assess mortality of enrolled patients by quarterly retrospective chart reviews.	Up to 2 years
Secondary	Length of hospital stay	Compare length of hospitalization between groups	up to 60 days
Secondary	Length of ICU stay	Compare length of ICU stay between groups	up to 30 days
Secondary	Discharge location	was patient discharged to home, rehabilitation facility, skilled nursing, death; compare between groups	up to 60 days
Secondary	Complications	Compare complications (such as need to be mechanically ventilated, infections, etc.) between groups	up to 2 years